Thursday, December 15, 2016

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

›
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.  Scientists have iden...
Wednesday, December 14, 2016

Antimuscarinic drugs effective in improving OAB symptoms

›
In a recent study of patients with overactive bladder (OAB), a 30 mg extended release formulation of propiverine hydrochloride was at lea...
Tuesday, December 13, 2016

Taking vitamin D with quetiapine can help avoid new-onset diabetes risk

›
In continuation of my update on quetiapine Atypical antipsychotics, though effective for treating disorders like schizophrenia, bipola...
Monday, December 12, 2016

Walnuts may improve your colon health: Eating walnuts changes the gut microbiome and reduces cancer growth, study shows

›
In continuation of my update on walnuts    A team of researchers from UConn Health and The Jackson Laboratory for Genomic Medicine...
Friday, December 9, 2016

Topical skin creams effective to treat superficial basal cell carcinoma

›
In continuation of my update on  imiquimod and fluorouracil Basal cell carcinoma is one of the most common cancers and its incidence is ...
Thursday, December 8, 2016

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

›
A promising new compound appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the tre...
Wednesday, December 7, 2016

Specific commercial red algae could help combat food allergies

›
  Seaweed has long been a staple food in many Asian countries and has recently caught on as a snack food in America as a healthful alt...
Tuesday, December 6, 2016

FDA Expands Indication of Invokamet (canagliflozin/metformin HCl) to Include First-Line Treatment of Type 2 Diabetes

›
In continuation of my updates on  INVOKANA® ( canagliflozin ) and metformin hydrochloride, Janssen Pharmaceuticals, Inc. (Janssen), anno...
Monday, December 5, 2016

FDA Grants Accelerated Approval to Ocaliva (obeticholic acid) for Primary Biliary Cholangitis

›
Intercept Pharmaceuticals, Inc.   a biopharmaceutical company focused on the development and commercialization of novel therapeutics to tr...
Friday, December 2, 2016

FDA Approves Lenvima (lenvatinib) for the Treatment of Patients with Advanced Renal Cell Carcinoma

›
In continuation of my update on  Lenvatinib   Lenvatinib Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA)...
Thursday, December 1, 2016

Theravance Biopharma Announces FDA Approval of Expanded Label for Vibativ (telavancin)

›
In continuation of my update on telavan cin Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the ...